Cargando…

Identification of ethyl pyruvate as a NLRP3 inflammasome inhibitor that preserves mitochondrial integrity

BACKGROUND: The NLRP3 inflammasome, a cytosolic complex that mediates the maturation of IL-1β and IL-18 as well as the release of high mobility group box 1 (HMGB1), contributes to the lethality of endotoxic shock. Ethyl pyruvate (EP) was previously shown to inhibit HMGB1 release and promote survival...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Sujun, Liang, Fang, Kwan, Kevin, Tang, Yiting, Wang, Xiangyu, Tang, Youzhou, Li, Jianhua, Yang, Huan, Chavan, Sangeeta S., Wang, Haichao, Andersson, Ulf, Lu, Ben, Tracey, Kevin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016887/ https://www.ncbi.nlm.nih.gov/pubmed/30134814 http://dx.doi.org/10.1186/s10020-018-0006-9

Ejemplares similares

Ethyl pyruvate protects against sepsis-associated encephalopathy through inhibiting the NLRP3 inflammasome
por: Zhong, Xiaoli, et al.
Publicado: (2020)

Novel role of PKR in inflammasome activation and HMGB1 release
por: Lu, Ben, et al.
Publicado: (2012)

Protective Effect of Ethyl Pyruvate against Myocardial Ischemia Reperfusion Injury through Regulations of ROS-Related NLRP3 Inflammasome Activation
por: Jun, Ji Hae, et al.
Publicado: (2019)

Ethyl Pyruvate Attenuates Microglial NLRP3 Inflammasome Activation via Inhibition of HMGB1/NF-κB/miR-223 Signaling
por: Olcum, Melis, et al.
Publicado: (2021)

Pyruvate dehydrogenase kinase supports macrophage NLRP3 inflammasome activation during acute inflammation
por: Meyers, Allison K., et al.
Publicado: (2023)

RAB20 deficiency promotes the development of silicosis via NLRP3 inflammasome
por: Peng, Zhouyangfan, et al.
Publicado: (2022)

A 4-Benzene-Indol Derivative Alleviates LPS-Induced Acute Lung Injury Through Inhibiting the NLRP3 Inflammasome
por: Li, Junmei, et al.
Publicado: (2022)

SIRT1 agonism modulates cardiac NLRP3 inflammasome through pyruvate dehydrogenase during ischemia and reperfusion
por: Han, Ying, et al.
Publicado: (2020)

PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation
por: Xie, Min, et al.
Publicado: (2016)

Targeting the NLRP3 Inflammasome in Severe COVID-19
por: Freeman, Tracey L., et al.
Publicado: (2020)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease Models
por: Das, Biswadeep, et al.
Publicado: (2021)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
por: Zhang, Tan, et al.
Publicado: (2021)

Impact of ethyl pyruvate on Adriamycin-induced cardiomyopathy in rats
por: Liu, Menglin, et al.
Publicado: (2016)

Ethyl Pyruvate Induces Tolerogenic Dendritic Cells
por: Djedovic, Neda, et al.
Publicado: (2019)

Ethyl Pyruvate Ameliorates Experimental Autoimmune Myocarditis
por: Gajić, Dragica, et al.
Publicado: (2021)

Oroxylin A inhibits colitis by inactivating NLRP3 inflammasome
por: Zhou, Wei, et al.
Publicado: (2017)

NLRP3 Inflammasome Pharmacological Inhibitors in Glycyrrhiza for NLRP3-Driven Diseases Treatment: Extinguishing the Fire of Inflammation
por: Wang, Zhilei, et al.
Publicado: (2022)

CB1R-stabilized NLRP3 inflammasome drives antipsychotics cardiotoxicity
por: Li, Liliang, et al.
Publicado: (2022)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

NLRP3 Inflammasome and Inflammatory Diseases
por: Wang, Zheng, et al.
Publicado: (2020)

Apigenin attenuates atherosclerosis and non-alcoholic fatty liver disease through inhibition of NLRP3 inflammasome in mice
por: Lu, Zheng, et al.
Publicado: (2023)

Perfluorodecanoic acid stimulates NLRP3 inflammasome assembly in gastric cells
por: Zhou, Xiangyu, et al.
Publicado: (2017)

NLRP3 inflammasome in endothelial dysfunction
por: Bai, Baochen, et al.
Publicado: (2020)

Protective effects of ethyl pyruvate in cisplatin-induced nephrotoxicity
por: Kelle, Ilker, et al.
Publicado: (2014)

The anticoagulant effects of ethyl pyruvate in whole blood samples
por: Haidl, Harald, et al.
Publicado: (2020)

Ethyl pyruvate, a versatile protector in inflammation and autoimmunity
por: Koprivica, Ivan, et al.
Publicado: (2022)

Highly Selective Oxidation of Ethyl Lactate to Ethyl Pyruvate Catalyzed by Mesoporous Vanadia–Titania
por: Zhang, Wei, et al.
Publicado: (2018)

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
por: Saresella, Marina, et al.
Publicado: (2016)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
por: Kim, Yang Gyun, et al.
Publicado: (2019)

NLRP3 inflammasome activation in murine macrophages caused by Neospora caninum infection
por: Wang, Xiaocen, et al.
Publicado: (2017)

Effects of ethyl pyruvate on cardiac function recovery and apoptosis reduction after global cold ischemia and reperfusion
por: GUO, JIALONG, et al.
Publicado: (2014)

NLRP3 inflammasome activation in response to metals
por: Huang, Wanyi, et al.
Publicado: (2023)

The role of NLRP3 inflammasome in hepatocellular carcinoma
por: Zhao, Huijie, et al.
Publicado: (2023)

The trigger for pancreatic disease: NLRP3 inflammasome
por: Liu, Tianming, et al.
Publicado: (2023)

NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
por: Paramel Varghese, Geena, et al.
Publicado: (2016)

NLRP3 Inflammasome Participates in Host Response to Neospora caninum Infection
por: Wang, Xiaocen, et al.
Publicado: (2018)

Targeting NLRP3 Inflammasome in Translational Treatment of Nervous System Diseases: An Update
por: Yu, Qingying, et al.
Publicado: (2021)

Contribution of Toll-Like Receptors and the NLRP3 Inflammasome in Rheumatoid Arthritis Pathophysiology
por: Unterberger, Sarah, et al.
Publicado: (2021)

The role of the NLRP3 inflammasome in gout
por: Kingsbury, Sarah R, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ls8fh187v3cjoavses6j92piju